These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7813220)

  • 1. Effect of prophylactic antibiotics on morbidity associated with IUD insertion: results of a pilot randomized controlled trial. IUD Study Group.
    Walsh TL; Bernstein GS; Grimes DA; Frezieres R; Bernstein L; Coulson AH
    Contraception; 1994 Oct; 50(4):319-27. PubMed ID: 7813220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic prophylaxis for intrauterine contraceptive device insertion.
    Grimes DA; Schulz KF
    Cochrane Database Syst Rev; 2001; (2):CD001327. PubMed ID: 11405986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised controlled trial of prophylactic antibiotics before insertion of intrauterine devices. IUD Study Group.
    Walsh T; Grimes D; Frezieres R; Nelson A; Bernstein L; Coulson A; Bernstein G
    Lancet; 1998 Apr; 351(9108):1005-8. PubMed ID: 9546505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic prophylaxis for intrauterine contraceptive device insertion.
    Grimes DA; Schulz KF
    Cochrane Database Syst Rev; 2001; (1):CD001327. PubMed ID: 11279714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic antibiotics for intrauterine device insertion: a metaanalysis of the randomized controlled trials.
    Grimes DA; Schulz KF
    Contraception; 1999 Aug; 60(2):57-63. PubMed ID: 10592851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic prophylaxis for intrauterine contraceptive device insertion.
    Grimes DA; Schulz KF
    Cochrane Database Syst Rev; 2000; 1999(2):CD001327. PubMed ID: 10796777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical performance of the TCu 380A and Lippes Loop IUDs in three developing countries.
    Farr G; Amatya R; Acosta M; Ekwempu C; Kisninci H
    Contraception; 1995 Jul; 52(1):17-22. PubMed ID: 8521710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing IUCD-related pelvic infection: the efficacy of prophylactic doxycycline at insertion.
    Sinei SK; Schulz KF; Lamptey PR; Grimes DA; Mati JK; Rosenthal SM; Rosenberg MJ; Riara G; Njage PN; Bhullar VB
    Br J Obstet Gynaecol; 1990 May; 97(5):412-9. PubMed ID: 2196934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performances of copper T 380A and multiload copper 375/250 intrauterine contraceptive devices in a comparative clinical trial.
    Arowojolu AO; Otolorin EO; Ladipo OA
    Afr J Med Med Sci; 1995 Mar; 24(1):59-65. PubMed ID: 7495202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of IUD-related pelvic infection: the efficacy of prophylactic doxycycline at IUD insertion.
    Ladipo OA; Farr G; Otolorin E; Konje JC; Sturgen K; Cox P; Champion CB
    Adv Contracept; 1991 Mar; 7(1):43-54. PubMed ID: 1872196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between intrauterine contraceptive device use and breast-feeding status at time of intrauterine contraceptive device insertion: analysis of TCu-380A acceptors in developing countries.
    Farr G; Rivera R
    Am J Obstet Gynecol; 1992 Jul; 167(1):144-51. PubMed ID: 1442918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications of use of intrauterine devices among HIV-1-infected women.
    Sinei SK; Morrison CS; Sekadde-Kigondu C; Allen M; Kokonya D
    Lancet; 1998 Apr; 351(9111):1238-41. PubMed ID: 9643743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrauterine devices and pelvic inflammatory disease: an international perspective.
    Farley TM; Rosenberg MJ; Rowe PJ; Chen JH; Meirik O
    Lancet; 1992 Mar; 339(8796):785-8. PubMed ID: 1347812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of the removal of the intrauterine device in genital colonization by actinomyces.
    Bonacho I; Pita S; Gómez-Besteiro MI
    Gynecol Obstet Invest; 2001; 52(2):119-23. PubMed ID: 11586040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genital tract infections associated with the intrauterine contraceptive device can be reduced by inserting the threads into the uterine cavity.
    Pap-Akeson M; Solheim F; Thorbert G; Akerlund M
    Br J Obstet Gynaecol; 1992 Aug; 99(8):676-9. PubMed ID: 1390474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prophylactic use of prostaglandin synthesis inhibitors in connection with IUD insertion].
    Jensen HH; Blaabjerg J; Lyndrup J
    Ugeskr Laeger; 1998 Nov; 160(48):6958-61. PubMed ID: 9846090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrauterine contraceptive insertion postabortion: a systematic review.
    Steenland MW; Tepper NK; Curtis KM; Kapp N
    Contraception; 2011 Nov; 84(5):447-64. PubMed ID: 22018119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing infection related to insertion of an intrauterine device.
    Jovanovic R; Barone CM; Van Natta FC; Congema E
    J Reprod Med; 1988 Apr; 33(4):347-52. PubMed ID: 3367334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retention of intrauterine devices in women who acquire pelvic inflammatory disease: a systematic review.
    Tepper NK; Steenland MW; Gaffield ME; Marchbanks PA; Curtis KM
    Contraception; 2013 May; 87(5):655-60. PubMed ID: 23040135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.